FDA Import Refusal SCS-1338938-6/11/1 — Novo Nordisk Inc.
The FDA refused shipment SCS-1338938-6/11/1 from Novo Nordisk Inc. (United States) on Dec 15, 2023. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Dec 15, 2023
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75